Demographic factors
Inclusion Criteria: All patients Timing: Baseline Data Source: Clinical or patient-‐reported Type: Date by DD/MM/YYYY
date
Inclusion Criteria: All patients Timing: Baseline Data Source: Clinical or patient-‐reported Type: Single answer
integer
Baseline Clinical Factors
Inclusion Criteria: Patients undergoing surgery Timing: Baseline Data Source: Clinical Type: Numerical value Response Options: Numerical value in liters 999 = Unknown
float
Inclusion Criteria: Patients undergoing surgery Timing: Baseline Data Source: Clinical Type: Numerical value Response Options: Numerical value of 0‐100 999 = Unknown
float
Baseline tumor factors
Inclusion Criteria: All patients Timing: Baseline Data Source: Clinical Type: Single answer
integer
Inclusion Criteria: All patients Timing: Baseline Data Source: Clinical Type: Single answer
integer
Supporting Definition: If the test is not performed, unknown can be answered. Inclusion Criteria: All patients Timing: Baseline Data Source: Clinical Type: Single answer
integer
Supporting Definition: If the test is not performed, unknown can be answered. Inclusion Criteria: All patients Timing: Baseline Data Source: Clinical Type: Single answer
integer
Supporting Definition: Pathologic staging preferred, if available cT0: no primary tumor cT1: if not able to select T1a or T1b: Tumor ≤3 cm diameter, surrounded by lung or visceral pleura, without invasion more proximal than lobar bronchus cT1a: Tumor ≤2 cm in diameter cT1b: Tumor >2 cm but ≤3 cm in diameter cT2: if not able to select T2a or T2b: Tumor >3 cm but ≤7 cm, or tumor with any of the following features: Involves main bronchus, ≥2 cm distal to carina. Invades visceral pleura. Associated with atelectasis or obstructive pneumonitis that extends to the hilar region but does not involve the entire lung cT2a: Tumor >3 cm but ≤5 cm cT2b: Tumor >5 cm but ≤7 cm cT3: Tumor >7 cm or any of the following: Directly invades any of the following: chest wall, diaphragm, phrenic nerve, mediastinal pleura, parietal pericardium, main bronchus <2 cm from carina (without involvement of carina), Atelectasis or obstructive pneumonitis of the entire lung. Separate tumor nodules in the same lobe cT4: Tumor of any size that invades the mediastinum, heart, great vessels, trachea, recurrent laryngeal nerve, esophagus, vertebral body, carina, or with separate tumor nodules in a different ipsilateral lobe cTX: Primary tumor cannot be assessed Inclusion Criteria: All patients Timing: Baseline Data Source: Clinical Type: Single answer
integer
Supporting Definition: Pathologic staging preferred, if available cN0: No regional lymph node metastases cN1: Metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary nodes, including involvement by direct extension cN2: Metastasis in ipsilateral mediastinal and/or subcarinal lymph node(s) cN3: Metastasis in contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene, or supraclavicular lymph node(s) cNX: Regional lymph nodes were not assessed Inclusion Criteria: All patients Timing: Baseline Data Source: Clinical Type: Single answer
integer
Supporting Definition: cM0: No distant metastasis cM1: Distant metastasis cM1a: Separate tumor nodule(s) in a contralateral lobe; tumor with pleural nodules or malignant pleural or pericardial effusion cM1b: Distant metastasis (in extrathoracic organs) cMX: Distant metastasis cannot be evaluated Inclusion Criteria: All patients Timing: Baseline Data Source: Clinical Type: Single answer
integer
Supporting Definition: pM0: No distant metastasis pM1: Distant metastasis pM1a: Separate tumor nodule(s) in a contralateral lobe; tumor with pleural nodules or malignant pleural or pericardial effusion pM1b: Distant metastasis (in extrathoracic organs) pMX: Distant metastasis cannot be evaluated Inclusion Criteria: All patients Timing: Baseline Data Source: Clinical Type: Single answer
integer
Degree of health
Supporting Definition: ECOG / WHO scale: - PS = 0 normal activity level; - PS = 1 restricted with strenuous activity, but can do light activity; - PS = 2 active >/= 50% of day; - PS = 3 spends >50% of day in chair or bed; - PS = 4 totally confined to bed Inclusion Criteria: All patients Timing: Baseline 1 year post initiation of treatment Tracked ongoing annually for life (when hospital is able to track this ongoing) Data Source: Clinical Type: Single answer
integer